formaldehyde has been researched along with Peripheral Nerve Diseases in 18 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
| Excerpt | Relevance | Reference |
|---|---|---|
| "An excess of excitatory pathway activation via N-methyl-D-aspartate (NMDA) receptors has been described in neuropathic pain that responds poorly to morphine." | 7.71 | Magnesium increases morphine analgesic effect in different experimental models of pain. ( Begon, S; Dubray, C; Eschalier, A; Pickering, G, 2002) |
| "It had less effect on tactile allodynia (CCI)." | 5.35 | Effects of norketamine enantiomers in rodent models of persistent pain. ( Crooks, PA; Hojomat, M; Holtman, JR; Johnson-Hardy, JK; Kleven, M; Wala, EP, 2008) |
| "Development of peripheral neuropathy, which can present as painful neuropathy or loss of sensation, sometimes limit the use of paclitaxel in the treatment of solid tumors such as breast cancer." | 3.80 | Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline. ( Masocha, W, 2014) |
| " In the present study, morphine (a low dose) was combined with S(+)- and R(-)-norketamine (sub-antinociceptive doses) and characterized utilizing rodent models of pain including: thermal nociception (the tail-flick test), peripheral neuropathy (chronic constriction nerve injury) and tonic inflammatory pain (the formalin test)." | 3.74 | Interaction between morphine and norketamine enantiomers in rodent models of nociception. ( Crooks, PA; Holtman, JR; Johnson-Hardy, J; Wala, EP, 2008) |
| " In order to determine if the endogenous opioid system is involved in this antinociception, naloxone was administered just prior to the injection of a selective P2X3/P2X2/3 receptor antagonist, A-317491, in rat models of neuropathic, chemogenic, and inflammatory pain." | 3.73 | Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. ( Bianchi, B; Faltynek, CR; Honore, P; Jarvis, MF; McDonald, HA; McGaraughty, S; Mikusa, J; Wismer, CT; Zhu, CZ, 2005) |
| "An excess of excitatory pathway activation via N-methyl-D-aspartate (NMDA) receptors has been described in neuropathic pain that responds poorly to morphine." | 3.71 | Magnesium increases morphine analgesic effect in different experimental models of pain. ( Begon, S; Dubray, C; Eschalier, A; Pickering, G, 2002) |
| "It had less effect on tactile allodynia (CCI)." | 1.35 | Effects of norketamine enantiomers in rodent models of persistent pain. ( Crooks, PA; Hojomat, M; Holtman, JR; Johnson-Hardy, JK; Kleven, M; Wala, EP, 2008) |
| "Fenfluramine is an indirect agonist of 5-hydroxytryptamine (5-HT) receptors that acts by evoking 5-HT release and blocking 5-HT reuptake in neuronal cells." | 1.30 | Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. ( Bowersox, SS; Gao, D; Pettus, M; Wang, YX, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masocha, W | 1 |
| Holtman, JR | 2 |
| Crooks, PA | 2 |
| Johnson-Hardy, J | 1 |
| Wala, EP | 2 |
| Johnson-Hardy, JK | 1 |
| Hojomat, M | 1 |
| Kleven, M | 1 |
| Leo, S | 1 |
| Moechars, D | 1 |
| Callaerts-Vegh, Z | 1 |
| D'Hooge, R | 1 |
| Meert, T | 1 |
| Clapper, JR | 1 |
| Moreno-Sanz, G | 1 |
| Russo, R | 1 |
| Guijarro, A | 1 |
| Vacondio, F | 1 |
| Duranti, A | 1 |
| Tontini, A | 1 |
| Sanchini, S | 1 |
| Sciolino, NR | 1 |
| Spradley, JM | 1 |
| Hohmann, AG | 1 |
| Calignano, A | 1 |
| Mor, M | 1 |
| Tarzia, G | 1 |
| Piomelli, D | 1 |
| Wei, H | 1 |
| Koivisto, A | 1 |
| Saarnilehto, M | 1 |
| Chapman, H | 1 |
| Kuokkanen, K | 1 |
| Hao, B | 1 |
| Huang, JL | 1 |
| Wang, YX | 3 |
| Pertovaara, A | 1 |
| Simmons, RM | 1 |
| Webster, AA | 1 |
| Kalra, AB | 1 |
| Iyengar, S | 1 |
| McGaraughty, S | 1 |
| Honore, P | 1 |
| Wismer, CT | 1 |
| Mikusa, J | 1 |
| Zhu, CZ | 1 |
| McDonald, HA | 1 |
| Bianchi, B | 1 |
| Faltynek, CR | 1 |
| Jarvis, MF | 1 |
| Hizue, M | 1 |
| Pang, CH | 1 |
| Yokoyama, M | 1 |
| Hösl, K | 1 |
| Reinold, H | 1 |
| Harvey, RJ | 1 |
| Müller, U | 1 |
| Narumiya, S | 1 |
| Zeilhofer, HU | 1 |
| Honda, K | 1 |
| Takano, Y | 1 |
| Tsuda, M | 1 |
| Ishii, S | 1 |
| Masuda, T | 1 |
| Hasegawa, S | 1 |
| Nakamura, K | 1 |
| Nagata, K | 1 |
| Yamashita, T | 1 |
| Furue, H | 1 |
| Tozaki-Saitoh, H | 1 |
| Yoshimura, M | 1 |
| Koizumi, S | 1 |
| Shimizu, T | 1 |
| Inoue, K | 1 |
| Menetski, J | 1 |
| Mistry, S | 1 |
| Lu, M | 1 |
| Mudgett, JS | 1 |
| Ransohoff, RM | 1 |
| Demartino, JA | 1 |
| Macintyre, DE | 1 |
| Abbadie, C | 1 |
| Bowersox, SS | 2 |
| Gadbois, T | 1 |
| Singh, T | 1 |
| Pettus, M | 2 |
| Luther, RR | 1 |
| Date, Y | 1 |
| Nakazato, M | 1 |
| Kangawa, K | 1 |
| Shirieda, K | 1 |
| Fujimoto, T | 1 |
| Matsukura, S | 1 |
| Gao, D | 1 |
| Begon, S | 1 |
| Pickering, G | 1 |
| Eschalier, A | 1 |
| Dubray, C | 1 |
| Tóth, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Magnesium Oral Supplementation to Reduce Pain in Patients With Severe Peripheral Arterial Occlusive Disease: The MAG-PAPER Randomized Clinical Trial[NCT02455726] | 150 participants (Anticipated) | Interventional | 2015-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for formaldehyde and Peripheral Nerve Diseases
| Article | Year |
|---|---|
[Experimental methods in pain using neuropathic and inflammatory animal models].
Topics: Animals; Diagnostic Techniques, Neurological; Disease Models, Animal; Formaldehyde; Hot Temperature; | 2007 |
17 other studies available for formaldehyde and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.
Topics: Animals; Breast Neoplasms; Female; Formaldehyde; Humans; Hyperalgesia; Mice; Minocycline; Nociceptio | 2014 |
Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Topics: Analgesics, Opioid; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Drug Combin | 2008 |
Effects of norketamine enantiomers in rodent models of persistent pain.
Topics: Animals; Behavior, Animal; Chronic Disease; Constriction, Pathologic; Dose-Response Relationship, Dr | 2008 |
Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity.
Topics: Animals; Ataxia; Behavior, Animal; Carrageenan; Constriction, Pathologic; Formaldehyde; Hot Temperat | 2009 |
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Carragee | 2010 |
Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the rat.
Topics: Acetanilides; Analysis of Variance; Animals; Ankyrins; Calcium Channels; Capsaicin; Cholecystokinin; | 2011 |
Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.
Topics: Animals; Ataxia; Chronic Disease; Excitatory Amino Acid Agonists; Formaldehyde; Injections, Intraper | 2002 |
Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
Topics: Analgesia; Animals; Arthritis, Experimental; Dose-Response Relationship, Drug; Endorphins; Formaldeh | 2005 |
Involvement of N-methyl-D-aspartate-type glutamate receptor epsilon1 and epsilon4 subunits in tonic inflammatory pain and neuropathic pain.
Topics: Animals; Formaldehyde; Inflammation; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Pain | 2005 |
Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor alpha3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection.
Topics: Animals; Formaldehyde; Hyperalgesia; Inflammation; Injections; Mice; Mice, Knockout; Neuralgia; Pain | 2006 |
Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor.
Topics: Animals; Behavior, Animal; Capsaicin; Cell Count; Enzyme Inhibitors; Excitatory Postsynaptic Potenti | 2007 |
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.
Topics: Animals; Astrocytes; Chemokine CCL2; Chemokines; Enzyme-Linked Immunosorbent Assay; Formaldehyde; Fr | 2007 |
Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
Topics: Analgesics; Animals; Calcium Channel Blockers; Disease Models, Animal; Formaldehyde; Ion Channel Gat | 1996 |
Detection of three transthyretin gene mutations in familial amyloidotic polyneuropathy by analysis of DNA extracted from formalin-fixed and paraffin-embedded tissues.
Topics: Aged; Amino Acid Sequence; Amyloidosis; Base Sequence; DNA; Female; Fixatives; Formaldehyde; Gene Re | 1997 |
Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Fenfluramine; Formaldehyde; | 1999 |
Magnesium increases morphine analgesic effect in different experimental models of pain.
Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Synergism; | 2002 |
Experiments on the mode of spreading of Marek's disease virus.
Topics: Animals; Avian Leukosis; Avian Leukosis Virus; Chick Embryo; Chickens; Formaldehyde; Methods; Periph | 1971 |